Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Qiagen N.V.

Market Cap 7.74B 6.68B 6.16B 5.77B 10.8B 736B 10.97B 72.72B 28.35B 358B 29.04B 28.42B 1,240B P/E Ratio 2026 *
17.8x
P/E Ratio 2027 * 17.1x
Enterprise Value 8.26B 7.14B 6.58B 6.16B 11.54B 786B 11.72B 77.67B 30.28B 382B 31.02B 30.36B 1,324B EV / Sales 2026 *
3.83x
EV / Sales 2027 * 3.58x
Free-Float
99.27%
Yield 2026 *
-
Yield 2027 * 0.5%
1 day-0.96%
1 week+1.04%
Current month+1.28%
1 month+9.97%
3 months-9.87%
6 months-22.14%
Current year-21.71%
1 week 36.23
Extreme 36.23
37.78
1 month 32.53
Extreme 32.53
38.1
Current year 32.53
Extreme 32.53
57.82
1 year 32.53
Extreme 32.53
57.82
3 years 32.53
Extreme 32.53
57.82
5 years 32.53
Extreme 32.53
64.74
10 years 23.11
Extreme 23.113
65.86
Manager TitleAgeSince
Chief Executive Officer 61 2019-10-06
Director of Finance/CFO 58 2003-12-31
Chief Operating Officer - 2022-03-31
Director TitleAgeSince
Director/Board Member 71 2003-12-31
Director/Board Member 77 2011-05-31
Director/Board Member 60 2021-01-07
Date Insider Type Main position Quantity % Market Cap.
25-10-22Sell

Chief Financial Officer

18,577 0.0085%
25-10-22Sell

Chief Financial Officer

31,423 0.0144%
25-10-22Sell

Chief Executive Officer

25,000 0.0115%
Change 5-day change 1-year change 3-year change Capi.($)
-0.96%+1.04%-25.71%-27.44% 7.74B
-0.35%-0.22%-15.03%-12.88% 42.96B
+3.11%+3.11%+274.29%+507.94% 31.73B
+0.22%-1.08%+14.03%-14.37% 30.22B
+1.62%-2.08%-4.36%+24.05% 28.94B
+4.09%-1.98%+11.99%+17.37% 23.87B
-1.63%+2.88%+53.73%+114.36% 13.57B
-0.40%-1.48%+7.48%+7.12% 12.96B
+1.14%+3.62% - - 13.39B
-0.74%-1.62%+105.71%+76.01% 12.2B
Average +0.47%-0.67%+46.90%+76.91% 21.76B
Weighted average by Cap. +0.74%-1.05%+51.71%+91.09%

Financials

2026 *2027 *
Net sales 2.16B 1.86B 1.72B 1.61B 3.01B 205B 3.06B 20.26B 7.9B 99.76B 8.09B 7.92B 345B 2.27B 1.96B 1.81B 1.69B 3.17B 216B 3.22B 21.36B 8.33B 105B 8.53B 8.35B 364B
Net income 406M 350M 323M 302M 566M 38.55B 575M 3.81B 1.49B 18.76B 1.52B 1.49B 64.96B 467M 403M 371M 348M 652M 44.36B 662M 4.39B 1.71B 21.59B 1.75B 1.71B 74.76B
Net Debt 526M 454M 419M 392M 734M 50B 746M 4.94B 1.93B 24.34B 1.97B 1.93B 84.27B 406M 350M 323M 302M 566M 38.55B 575M 3.81B 1.49B 18.76B 1.52B 1.49B 64.96B
Logo Qiagen N.V.
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
Employees
5,500
Date Price Change Volume
26-06-12 37.06 $ -0.96% 1,894,689
26-06-11 37.42 $ +1.08% 2,623,341
26-06-10 37.02 $ -1.93% 2,488,216
26-06-09 37.75 $ +4.20% 2,159,381
26-06-08 36.23 $ -1.23% 1,485,840
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
37.42USD
Average target price
43.82USD
Spread / Average Target
+17.10%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. QGEN Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!